Form 13-F position report

GILEAD SCIENCES INC

Reported by WealthTrust Axiom LLC

GILD CUSIP 375558103 Manager CIK 0001425949

Reported 40,175 shares, down 1,947 (4.6%) from the prior quarter.

Reported value 12.5%; share count -4.6% vs. the prior quarter.

Reduced
% of reported 13F value 1.4% This manager · Q3 2026
Shares 40,175 Quarter-end amount reported
Reported value $5,988,043 Fair value at quarter end
Consecutive quarters held 45 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 4312000
2022-03-31 3538000
2022-06-30 3630000
2022-09-30 3661000
2022-12-31 4834580
2023-03-31 4607671
2023-06-30 4280168
2023-09-30 4114062
2023-12-31 4458059
2024-03-31 3939097
2024-06-30 3642044
2024-09-30 4407057
2024-12-31 4789551
2025-03-31 5695759
2025-06-30 4941918
2025-09-30 4839434
2025-12-31 5252939
2026-03-31 5905328
2026-06-30 5321696
2026-09-30 5988043

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for GILEAD SCIENCES INC held by WealthTrust Axiom LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 40,175 -1,947 (-4.6%) 1.4% $5,988,043 2026-11-10
Q2 2026 Reduced 42,122 -250 (-0.6%) 1.19% $5,321,696 2026-08-11
Q1 2026 Reduced 42,372 -425 (-1.0%) 1.45% $5,905,328 2026-05-11
Q4 2025 Reduced 42,797 -802 (-1.8%) 1.35% $5,252,939 2026-02-13
Q3 2025 Reduced 43,599 -975 (-2.2%) 1.3% $4,839,434 2025-11-14
Q2 2025 Reduced 44,574 -6,258 (-12.3%) 1.45% $4,941,918 2025-08-13
Q1 2025 Reduced 50,832 -1,020 (-2.0%) 1.73% $5,695,759 2025-05-14
Q4 2024 Reduced 51,852 -713 (-1.4%) 1.43% $4,789,551 2025-02-13
Q3 2024 Reduced 52,565 -518 (-1.0%) 1.31% $4,407,057 2024-11-13
Q2 2024 Reduced 53,083 -693 (-1.3%) 1.21% $3,642,044 2024-08-13
Q1 2024 Reduced 53,776 -1,254 (-2.3%) 1.27% $3,939,097 2024-05-10
Q4 2023 Added 55,030 +132 (0.2%) 1.49% $4,458,059 2024-02-05
Q3 2023 Reduced 54,898 -638 (-1.1%) 1.48% $4,114,062 2023-11-03
Q2 2023 Added 55,536 +2 (0.0%) 1.42% $4,280,168 2023-08-04
Q1 2023 Reduced 55,534 -780 (-1.4%) 1.57% $4,607,671 2023-05-03
Q4 2022 Reduced 56,314 -3,033 (-5.1%) 1.69% $4,834,580 2023-01-31
Q3 2022 Added 59,347 +612 (1.0%) 1.4% $3,661,000 2022-11-03
Q2 2022 Reduced 58,735 -791 (-1.3%) 1.29% $3,630,000 2022-07-27
Q1 2022 Added 59,526 +131 (0.2%) 1.1% $3,538,000 2022-05-09
Q4 2021 Reduced 59,395 -604 (-1.0%) 1.38% $4,312,000 2022-02-02
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

2482 managers reported GILEAD SCIENCES INC for Q3 2026.

Managers reporting GILEAD SCIENCES INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 125,246,865 +3,402,757 0.27% $18,668,045,217 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 81,175,627 +83,893 0.25% $12,099,227,204 3 qtrs
STATE STREET CORPORATION Reduced 60,954,967 -261,585 0.26% $9,085,337,831 54 qtrs
FMR LLC Reduced 58,265,696 -8,605,120 0.37% $8,684,501,953 54 qtrs
Invesco Ltd Reduced 38,662,436 -1,156,715 0.45% $5,762,636,028 54 qtrs
Capital World Investors Reduced 35,929,833 -5,059,142 0.65% $5,355,872,692 54 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 35,685,818 +369,650 0.24% $5,318,971,173 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 30,190,640 +124,998 0.23% $4,485,711,723 54 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 27,664,121 -2,332,573 0.41% $4,123,338,000 54 qtrs
Capital Research Global Investors Added 23,980,766 +4,587,470 0.51% $3,574,341,919 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 10, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
0
Shared
0
None
40,175

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.